Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentostatin, Cyclophosphamide, and Ofatumumab in Untreated CLL/SLL
NCT01024010Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2010
- Primary completion
- May 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by Mayo Clinic. Started Mar 2010; status: completed.
02
Drugs
ofatumumab
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT01024010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01024010.